Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × fluzoparib × Clear all

NCT06516445 2024-07-24

SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms